Why Some Hedge Funds Aren’t Smarting Over JUUL’s Woes
Last year’s Altria deal may have saved the investments of hedge funds and others who earlier poured money into the embattled e-cigarette maker.
Another day, another round of bad news for JUUL.
The business model of the e-cigarette maker — and unofficially the third-most-valuable pre-IPO company — is under attack and its valuation is seemingly going up in smoke.
The controversial company is being blamed for the recent vaping deaths and the epidemic of teen vaping.